Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Mays

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|June 26, 2003
CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptomsL J Egan, G M Myhre, D C Mays, et al.
Gastroenterology|December 1, 1995
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's diseaseW J Sandborn, E C Van O, B J Zins, et al.
The American Journal of Gastroenterology|January 11, 2001
Intravenous azathioprine in severe ulcerative colitis: a pilot studyU Mahadevan, W J Tremaine, T Johnson, et al.
Biochemical Pharmacology|July 31, 1995
Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophilsD C Mays, L J Pawluk, G Apseloff, et al.
Journal of Chromatography. A|February 17, 1995
Simultaneous structure-activity determination of disulfiram photolysis products by on-line continuous-flow liquid secondary ion mass spectrometry and enzyme inhibition assayL M Benson, K A Veverka, D C Mays, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1987
Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometryD C Mays, S G Hecht, S E Unger, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolitesD C Mays, S L Rogers, R C Guiler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adductsD C Mays, J B Hilliard, D D Wong, et al.
Biochemical Pharmacology|March 1, 1995
S-methyl N,N-diethylthiocarbamate sulfone, a potential metabolite of disulfiram and potent inhibitor of low Km mitochondrial aldehyde dehydrogenaseD C Mays, A N Nelson, A H Fauq, et al.
Journal of Clinical Pharmacology|November 1, 1988
Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoinN Gerber, D C Mays, K H Donn, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|June 26, 2003
CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptomsL J Egan, G M Myhre, D C Mays, et al.
Gastroenterology|December 1, 1995
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's diseaseW J Sandborn, E C Van O, B J Zins, et al.
The American Journal of Gastroenterology|January 11, 2001
Intravenous azathioprine in severe ulcerative colitis: a pilot studyU Mahadevan, W J Tremaine, T Johnson, et al.
Biochemical Pharmacology|July 31, 1995
Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophilsD C Mays, L J Pawluk, G Apseloff, et al.
Journal of Chromatography. A|February 17, 1995
Simultaneous structure-activity determination of disulfiram photolysis products by on-line continuous-flow liquid secondary ion mass spectrometry and enzyme inhibition assayL M Benson, K A Veverka, D C Mays, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1987
Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometryD C Mays, S G Hecht, S E Unger, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolitesD C Mays, S L Rogers, R C Guiler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adductsD C Mays, J B Hilliard, D D Wong, et al.
Biochemical Pharmacology|March 1, 1995
S-methyl N,N-diethylthiocarbamate sulfone, a potential metabolite of disulfiram and potent inhibitor of low Km mitochondrial aldehyde dehydrogenaseD C Mays, A N Nelson, A H Fauq, et al.
Journal of Clinical Pharmacology|November 1, 1988
Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoinN Gerber, D C Mays, K H Donn, et al.
Pageof 6